Jan 29 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA PLC - COVID-19 VACCINE RECEIVES POSITIVE OPINION IN EU
* ASTRAZENECA - ASTRAZENECA ANTICIPATES EU WILL SHORTLY APPROVE A CMA FOR ACTIVE IMMUNISATION TO BEGIN ACROSS MEMBER STATES.
* ASTRAZENECA - ANTICIPATES EU WILL SHORTLY APPROVE A CMA FOR ACTIVE IMMUNISATION TO BEGIN ACROSS MEMBER STATES.
* ASTRAZENECA -ALSO SEEKING EMERGENCY USE LISTING FROM WORLD HEALTH ORGANIZATION FOR ACCELERATED PATHWAY TO VACCINE AVAILABILITY IN LOW-INCOME COUNTRIES
* ASTRAZENECA - ADDITIONAL SAFETY, EFFICACY DATA FOR VACCINE TO CONTINUE TO ACCUMULATE FROM ONGOING CLINICAL TRIALS, EXPECTED TO BE PUBLISHED IN COMING WEEKS Source text for Eikon: Further company coverage: